{
  "id": 4046076,
  "title": "FDA approves Takeda, Protagonist drug for rare blood disorder",
  "url": "https://urgent.news/2026/08/28/fda-approves-takeda-protagonist-drug-for-rare-blood-disorder",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-28T22:15:30.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/fda-approves-takeda-protagonist-drug-for-rare-blood-disorder/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The FDA approved rusfertide, a new drug from Takeda and Protagonist Therapeutics to treat a rare blood disease. Rusfertide, which will be branded as Mimrylo, can now be prescribed for polycythemia vera, a disease in ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}